Statistics
Publications
13
Citations
9.5K
H-Index
13
Active since
2006
Kreshnik Zejnullahu is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and molecular oncology.
Publications per year
2006–2017
13
13
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
Alexa B. Turke, Kreshnik Zejnullahu, Yi‐Long Wu et al. · Cancer Cell · 2010 · 1.1K citations · Full text
<i>EML4-ALK</i> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
Jussi Koivunen, Craig H. Mermel, Kreshnik Zejnullahu et al. · Clinical Cancer Research · 2008 · 983 citations · Full text
Medicine, Oncology, Pharmacology +17
Jeffrey A. Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale et al. · Cancer Research · 2007 · 718 citations · Full text
Medicine, Oncology, Pharmacology +13
1–5 of 13